Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02386514 · ClinicalTrials.gov registry record

Emergency Department, Rapid Assessment for Sexually Transmitted Infection

A clinical trial, sponsored by Henry Ford Health System.

Completed
Registry status
1,200
Enrollment target

NCT02386514 is a clinical trial that has completed, run by Henry Ford Health System. The registered enrollment target is 1,200 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02386514 has completed, sponsored by Henry Ford Health System.

COMPLETED
Registry status
1,200 participants
Enrollment target

Study Summary

To evaluate if a rapid urine Nucleic Acid Amplification Testing (NAAT) is non-inferior to the traditional swab NAAT for gonorrhea and chlamydia when performed in the Emergency Department.

Trial Details

FieldValue
Enrollment Target 1,200 participants
Start Date 2016-06
Est. Completion 2016-06

Sponsor

Henry Ford Health System

234 total trials

What the Registry Record Tells You About NCT02386514

The ClinicalTrials.gov registry entry for NCT02386514 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Henry Ford Health System, which has 234 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT02386514 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02386514 about?

NCT02386514 is a clinical study titled "Emergency Department, Rapid Assessment for Sexually Transmitted Infection". To evaluate if a rapid urine Nucleic Acid Amplification Testing (NAAT) is non-inferior to the traditional swab NAAT for gonorrhea and chlamydia when performed in the Emergency Department.

What is the current status of trial NCT02386514?

This trial is currently completed. The enrollment target is 1,200 participants. The study started on 2016-06. Estimated completion is 2016-06.

Who is sponsoring clinical trial NCT02386514?

This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.